What Happened
- The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), the R&D wing of Tata Memorial Centre, is developing a mobile application to assess individual risk of developing breast, oral cavity, and gall bladder cancers
- The app is being developed by ACTREC's Centre for Cancer Epidemiology (CCE) under the direction of Dr Rajesh Dikshit
- The app for oral cavity and gall bladder cancer risk assessment is expected to launch within 3-4 months
- Users will input demographic and lifestyle parameters — for breast cancer, these include age, postmenopausal status, BMI, breast-to-hip ratio, number of children, and reproductive history
- The app assigns users to higher, middle, or lower risk groups, encouraging early screening for those identified as high-risk
- The initiative aims to improve awareness and promote early detection of cancers where India faces a significant disease burden
Static Topic Bridges
ACTREC and Tata Memorial Centre — India's Premier Cancer Research Infrastructure
The Tata Memorial Centre (TMC) is India's first comprehensive cancer centre, formed in 1966 by amalgamating the Indian Cancer Research Centre (established 1952) and Tata Memorial Hospital. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. ACTREC was conceptualised by the DAE in November 1983 and inaugurated in 2002 at Kharghar, Navi Mumbai. It is a 500-bed facility registering nearly 10,000 new patients annually. ACTREC functions as a premier training and research centre under the Homi Bhabha National Institute (HBNI), a deemed university under DAE. It conducts basic and clinical research in cancer biology and offers PhD programmes in life sciences.
- Tata Memorial Centre: established 1966, under Department of Atomic Energy
- ACTREC: conceptualised 1983, inaugurated 2002 at Kharghar, Navi Mumbai
- Capacity: 500-bed facility, ~10,000 new patients annually
- Parent body: DAE (Department of Atomic Energy), Government of India
- Academic affiliation: Homi Bhabha National Institute (deemed university)
- Centre for Cancer Epidemiology (CCE): division within ACTREC conducting population-based cancer research
Connection to this news: The cancer risk assessment app is a product of ACTREC's Centre for Cancer Epidemiology, leveraging decades of population-level cancer data collected through India's National Cancer Registry Programme. The DAE's involvement in cancer research is a legacy of the recognition that radiation biology and nuclear medicine are core to cancer treatment.
National Cancer Registry Programme (NCRP) and Cancer Burden in India
The National Cancer Registry Programme (NCRP) has been systematically collecting cancer data in India since 1981 through population-based cancer registries (PBCRs) and hospital-based cancer registries, coordinated by the ICMR-National Centre for Disease Informatics and Research (NCDIR), Bengaluru. India estimated approximately 14.6 lakh new cancer cases in 2022, projected to rise further. The three cancers targeted by the ACTREC app represent significant disease burdens: breast cancer is the most common cancer among Indian women (accounting for approximately 21.8% of cancer burden by DALYs); oral cavity cancer is disproportionately high in India due to tobacco and betel nut use; and gall bladder cancer has a distinctive geographic concentration in North India and the Gangetic belt, particularly among women.
- NCRP: established 1981, coordinated by ICMR-NCDIR, Bengaluru
- Estimated new cancer cases in India (2022): ~14.6 lakh
- Breast cancer: most common cancer in Indian women, ~21.8% of DALYs
- Oral cancer: India has one of the highest incidences globally (linked to tobacco, betel nut, gutka)
- Gall bladder cancer: highest incidence in North India, especially among women in the Gangetic belt
- Rising trends: tobacco-related and lifestyle-related cancers showing increasing incidence
- Data sources: 28 population-based cancer registries and 58 hospital-based cancer registries
Connection to this news: The app's focus on breast, oral, and gall bladder cancers is strategically chosen based on NCRP data — these represent cancers where India has uniquely high burden and where early detection through risk stratification can significantly improve outcomes.
Digital Health and mHealth in India — National Digital Health Mission
India's digital health ecosystem is anchored by the Ayushman Bharat Digital Mission (ABDM), launched in September 2021, which aims to create a national digital health infrastructure with a unique Ayushman Bharat Health Account (ABHA) for every citizen. The mission provides digital health IDs, a Health Facility Registry, and a Health Professional Registry. Mobile health (mHealth) applications are integral to this vision — the Aarogya Setu app (launched April 2020 for Covid-19 tracking) demonstrated mass adoption potential, reaching over 20 crore downloads. For cancer specifically, the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) operates through district NCD clinics for population-level screening.
- Ayushman Bharat Digital Mission (ABDM): launched September 2021
- ABHA (Ayushman Bharat Health Account): unique digital health ID for citizens
- Aarogya Setu: 20+ crore downloads (Covid-19 contact tracing, launched April 2020)
- NPCDCS: national programme for cancer, diabetes, CVD, stroke screening at district level
- Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY): health insurance for 10.74 crore families, covers cancer treatment up to Rs 5 lakh
- National Cancer Grid: network of 280+ cancer centres for uniform standards of care
Connection to this news: ACTREC's cancer risk assessment app aligns with India's broader digital health push under ABDM. By enabling risk stratification at the population level through a mobile app, it can serve as a pre-screening tool that channels high-risk individuals into the formal healthcare system for clinical screening under NPCDCS.
Key Facts & Data
- ACTREC: inaugurated 2002, 500-bed facility, ~10,000 new patients/year
- Parent body: Tata Memorial Centre under Department of Atomic Energy
- App targets: breast cancer, oral cavity cancer, gall bladder cancer
- Expected launch (oral and gall bladder modules): 3-4 months from March 2026
- NCRP: operating since 1981, 28 population-based + 58 hospital-based registries
- Estimated new cancer cases in India (2022): ~14.6 lakh
- Breast cancer: most common cancer in Indian women
- Oral cancer: India has among the highest global incidences (tobacco/betel nut link)
- National Cancer Grid: 280+ cancer centres networked